Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SHam-controlled INtErvention to Improve QOL in CTOs: the SHINE CTO Trial

NCT02784418 is registered in ClinicalTrials.gov with Minneapolis Heart Institute Foundation as lead sponsor.

NCT NCT02784418
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02784418 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SHam-controlled INtErvention to Improve QOL in CTOs: the SHINE CTO Trial
Lead sponsor
Minneapolis Heart Institute Foundation
Phase
Not applicable
Overall status
Withdrawn
Start date
May 31, 2016
Completion date
December 31, 2021
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic total occlusion of coronary artery, coronary artery disease, percutaneous transluminal coronary angioplasty